BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 6801682)

  • 1. Current status and trends in the treatment of hemophilic patients with inhibitors.
    Bloom AL
    Prog Clin Biol Res; 1981; 72():123-38. PubMed ID: 6801682
    [No Abstract]   [Full Text] [Related]  

  • 2. Hereditary disorders of blood coagulation.
    Zieve PD; Levin J
    Major Probl Intern Med; 1976; 10():51-64. PubMed ID: 785116
    [No Abstract]   [Full Text] [Related]  

  • 3. The physiologic basis for therapy of classic hemophilia (factor 8 deficiency) and related disorders. Combined clinical staff conference at the National Institutes of Health.
    Ann Intern Med; 1967 Oct; 67(4):856-82. PubMed ID: 5299081
    [No Abstract]   [Full Text] [Related]  

  • 4. Transfusion therapy in congenital coagulopathies.
    Lusher JM
    Hematol Oncol Clin North Am; 1994 Dec; 8(6):1167-80. PubMed ID: 7860443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of single factor deficiencies: a case study approach.
    Marques MB
    Clin Lab Sci; 2003; 16(2):120-2. PubMed ID: 12757193
    [No Abstract]   [Full Text] [Related]  

  • 6. [Factor VIII inhibitors].
    Ruggeri ZM; Bader R; Coppola R; Mannuccio Mannucci P
    Ric Clin Lab; 1977; 7 Suppl 2():17-29. PubMed ID: 339315
    [No Abstract]   [Full Text] [Related]  

  • 7. Acquired hemophilia.
    Bouvry P; Recloux P
    Haematologica; 1994; 79(6):550-6. PubMed ID: 7896216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience with factor VIII: C inhibitors and acquired von Willebrand's disease in an adult at Ramathibodi Hospital.
    Angchaisuksiri P; Atichartakarn V; Pathepchotiwong K; Jootar S; Ungkanont A; Chuncharunee S
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():152-8. PubMed ID: 7886560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of hemophiliacs with inhibitors].
    Fujimaki M
    Rinsho Ketsueki; 1985 Jul; 26(7):1059-68. PubMed ID: 3932719
    [No Abstract]   [Full Text] [Related]  

  • 10. New alternatives and strategies in the treatment of inhibitors.
    Hoyer LW
    Prog Clin Biol Res; 1984; 150():367-72. PubMed ID: 6431440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of the hereditary coagulation disorders.
    Mason DY; Ingram GI
    Semin Hematol; 1971 Apr; 8(2):158-88. PubMed ID: 5313347
    [No Abstract]   [Full Text] [Related]  

  • 12. [Present possibilities in the treatment of hemophilia with the available inhibitors].
    Haracić M; Kamhi J; Kurto J
    Med Arh; 1983; 37(4):175-80. PubMed ID: 6443876
    [No Abstract]   [Full Text] [Related]  

  • 13. Current treatment of patients with inhibitors to factor VIII.
    Hilgartner MW
    Haematologia (Budap); 1986; 19(1):21-32. PubMed ID: 3087840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inhibitors (antibodies) directed against factor VIII in hemophilia A (author's transl)].
    Beck EA
    Ther Umsch; 1979 Apr; 36(4):326-9. PubMed ID: 377556
    [No Abstract]   [Full Text] [Related]  

  • 15. [A 56-year-old patient with bronchial asthma and massive psoas muscle hematoma].
    Holler E; Hiller E; Hopfinger C; Meissner H
    Internist (Berl); 1986 Jun; 27(6):400-2. PubMed ID: 3091526
    [No Abstract]   [Full Text] [Related]  

  • 16. Transfusion support for haemophiliacs.
    Allain JP
    Clin Haematol; 1984 Feb; 13(1):99-117. PubMed ID: 6426835
    [No Abstract]   [Full Text] [Related]  

  • 17. Development and present status of concentrate therapy for hemophilia and von Willebrand's disease.
    Brinkhous KM
    Wien Klin Wochenschr; 1982 Oct; 94(19):509-14. PubMed ID: 6818773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current status and future prospects for the prophylactic management of hemophilia patients with inhibitor antibodies.
    Teitel JM; Sholzberg M
    Blood Rev; 2013 Mar; 27(2):103-9. PubMed ID: 23452718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Von Willebrand factor in high-purity factor VIII complex concentrates: chaperone protein or key to therapies? A meeting report.
    Federici AB; Mannucci PM; Marco P
    Haemophilia; 2008 Jan; 14(1):133-9. PubMed ID: 17941830
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cellular immunology status in 5 hemophilic patients with inhibitors subjected to massive therapy with factor VIII concentrate].
    Aznar JA; Jorquera JI; González Molina A; Carbonell F; Trenor A; Sánchez Cuenca JM; de Andrés R
    Sangre (Barc); 1983; 28(5):663-4. PubMed ID: 6420915
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.